Triple Anti-oxidant Therapy
Anti-oxidant approaches to cancer and hepatitis C.
Som
e anti-oxidants have been researched for both treatment of viruses and cancer, but it is not yet a standard or widely accepted treatment, and more research is needed. However, there are some remarkable case studies of patients with this regimen. There are case studies of patients with hepatitis C that have complete resolution of their virus with the triple anti-oxidant therapy.
Components
Alpha-lipoic acid (ALA)
A compound made in the cell mitochondria. It can potentially enhance immune function, effecting the mechanisms in tumor prevention and anti-cancer activity. Maintenance dose: 300 mg twice a day.
Silymarin
Found in milk thistle, it has both anti-oxidant and anti-inflammatory properties that may protect against viral damage. Maintenance dose: 300 mg three to four times per day.
Selenium (selenomethionine)
An essential mineral that plays a role in immune function and may have antiviral properties. Maintenance dosage: 200 mcg one to two times a day.
Glutathione
An antioxidant made in the body, associated with white blood cell leukocyte proliferation, enhanced immune system function, and effective antiviral protection.
Low dose naltrexone (LDN)
Impacts the survival, proliferation, and invasion of cancer cells, and has been suggested as an adjuvant in chemotherapy and immunotherapy. Typically prescribed: 4.5 mg at night.